# Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001)

> **NCT03882047** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 313 (actual)

## Conditions studied

- Rhinitis, Allergic, Seasonal

## Interventions

- **DRUG:** Mometasone furoate
- **DRUG:** Fluticasone propionate
- **DRUG:** Mometasone furoate placebo
- **DRUG:** Fluticasone propionate placebo

## Key facts

- **NCT ID:** NCT03882047
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-08-11
- **Primary completion:** 1994-09-16
- **Final completion:** 1994-09-16
- **Target enrollment:** 313 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03882047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03882047, "Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03882047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*